Testosterone and Neural Function
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT06130449
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Spinal Cord Injury
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Natesto testosterone intranasal gel — DRUGA single dose of Natesto (11 mg total, 5.5 mg per nostril) will be administered to each participant.
- Ayr Saline Nasal Gel — DRUGA single dose of Ayr (one spray per nostril) will be administered to each participant.
Study Details
Spinal cord injury (SCI) disrupts the nerves controlling movement, along with those that regulate functions like heart rate and blood pressure (known as the autonomic nervous system, or ANS). Testosterone (T) plays a significant role in brain health and ANS reflex function in non-neurologically impaired men. However, little is known about the relationships between T, nerve function, and ANS dysfunction after SCI. Interestingly, up to 60% of men with SCI exhibit persistently low T concentrations, which may worsen nerve and ANS dysfunction. In uninjured eugonadal people (normal physiologic range of serum T concentrations), a single pharmacologic dose of intranasal T has been shown to quickly improve nerve function, but no study has evaluated if T administration alters nerve and ANS function in men with SCI. Herein, the investigators will conduct the first study to test how a single dose of intranasal T impacts motor and ANS function in this population.
Key Dates
- Start date
- Apr 1, 2024
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: PlaceboParticipant-blinded (Ayr Saline Gel)
- Active Comparator: Intranasal TRTParticipant-blinded (11 mg of Natesto)
Primary Outcome Measure
Electromyographic (EMG) responses [ Time Frame: up to one day ]
Central Contacts
- Jacob A Goldsmith, PhD(718) 584-9000
- Noam Y Harel, MD PhD(718) 584-9000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| James J. Peters VA Medical Center, Bronx, NY | The Bronx | New York | 10468-3904 | Jacob A Goldsmith, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in The Bronx, NY
Related Studies
- Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or ParesisEARLY_PHASE1 · Recruiting · Northwell Health · Manhasset, New York
- Autonomic Effects of Stimulation in SCIRecruiting · VA Office of Research and Development · The Bronx, New York
- Time Restricted Eating to Mitigate Obesity in Veterans With Spinal Cord InjuryEnrolling By Invitation · VA Office of Research and Development · Syracuse, New York
- Leg Stretching Using an Exoskeleton on Demand for People With SpasticityRecruiting · VA Office of Research and Development · Syracuse, New York